Abstracts tagged "Osteoarthritis"

Abstract Number: 2469 • 2012 ACR/ARHP Annual Meeting
A Virtual Knee Joint Replacement Clinical Endpoint Based On Longitudinal Trends and Thresholds in Koos Knee Pain and Function in Osteoarthritis Initiative Participants
Robert M. Boudreau¹, David J. Hunter², Zhijie Wang³, Frank Roemer⁴, Felix Eckstein⁵, Michael J. Hannon³, Ali Guermazi⁶ and C. Kent Kwoh⁷, ¹Epidemiology, University of Pittsburgh, Pittsburgh, PA, ²Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ³Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁴Radiology, Boston University School of Medicine, Boston, MA, ⁵Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ⁶Boston University, Boston, MA, ⁷School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Knee joint replacement (KR) is a cost-effective procedure with good long-term outcomes, but has limitations as an endpoint in OA intervention trials. A definition…
Abstract Number: 1104 • 2012 ACR/ARHP Annual Meeting
The Association of Demographic, Modifiable, Structural and Biomechanical Risk Factors with Medial and Lateral Patellofemoral Joint Structural Damage On MRI: The Multicenter Osteoarthritis Study
Joshua J. Stefanik¹, Ke Wang², K. Douglas Gross³, Frank Roemer⁴, John A. Lynch⁵, Neil Segal⁶, Cora E. Lewis⁷, Michael C. Nevitt⁸, Ali Guermazi⁹ and David T. Felson¹⁰, ¹Clinical Epidemiology, Boston University, Boston, MA, ²Biostatistics, Boston University, Boston, MA, ³Physical Therapy, MGH Institute of Health Professions, Boston, MA, ⁴Klinikum Augsburg, Augsburg, Germany, ⁵Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, ⁶Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, ⁷Preventive Medicine, University of Alabama, Birmingham City, Birmingham, AL, ⁸Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁹Radiology, Boston University, Boston, MA, ¹⁰Boston University, Boston, MA
Background/Purpose: Past investigations into risk factors for patellofemoral joint (PFJ) osteoarthritis (OA) have been limited by the use of radiography, which is insensitive to identify…
Abstract Number: 251 • 2012 ACR/ARHP Annual Meeting
Smaller Baseline and Follow-up Quadriceps Muscle Cross-Sectional Area Increases the Odds of Knee Replacement in Knee Osteoarthritis
Serter Gumus¹, Michael J. Hannon², Diana Kaya¹, C. Kent Kwoh³ and Kyongtae Ty Bae¹, ¹Radiology, University of Pittsburgh, Pittsburgh, PA, ²Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Knee osteoarthritis (OA) is one of the major causes of disability among elderly. Knee replacement (KR) is the final effective treatment of OA after…
Abstract Number: 2471 • 2012 ACR/ARHP Annual Meeting
Oral Glucosamine Sulphate for the Prevention of Knee Osteoarthritis in Overweight Females; The First Ever Preventive Randomized Controlled Trial
Jos Runhaar¹, Marienke van Middelkoop¹, Max Reijman², Edwin Oei³, Dammis Vroegindeweij⁴, Gerjo van Osch², Bart Koes¹ and Sita Bierma-Zeinstra⁵, ¹General Practice, Erasmus MC, Rotterdam, Netherlands, ²Orthopaedics, Erasmus MC, Rotterdam, Netherlands, ³Radiology, Erasmus MC, Rotterdam, Netherlands, ⁴Radiology, Maasstad Hospital, Rotterdam, Netherlands, ⁵Orthopaedics and General Practice, Erasmus MC, Rotterdam, Netherlands
Background/Purpose: Previous studies showed the largest effects of glucosamine on osteoarthritis (OA) symptoms of the knee joint and when used in an early phase of…
Abstract Number: 1108 • 2012 ACR/ARHP Annual Meeting
A Randomized Controlled Trial of Hylan G-F 20 for the Treatment of Carpometacarpal Osteoarthritis
Lisa A. Mandl¹, Scott Wolfe², Aaron Daluiski², Robert N. Hotchkiss³, Stephen L. Lyman⁴ and Jeffrey N. Katz⁵, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Department of Orthopedics, Hospital For Special Surgery, New York, NY, ³Department of Orthopedics, Hospital for Special Surgery, New York, NY, ⁴Research, Hospital Special Surgery, New York, NY, ⁵Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Painful carpometacarpal osteoarthritis (CMC OA) is associated with substantial impairment, and is often unresponsive to medical treatment. Hylan G-F 20 has been shown…
Abstract Number: 255 • 2012 ACR/ARHP Annual Meeting
Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
O. Bruyere¹, N. Bellamy², J. Brown³, P. Richette⁴, L. Punzi⁵, X. Chevalier⁶, Cyrus Cooper⁷ and Jean-Yves Reginster¹, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, ³Rheumatology Centre,, Quebec City, QC, Canada, ⁴Centre Viggo Petersen / Service de Rhumatologie, Hôpital Lariboisière, Paris, France, ⁵Cattedra e Divisione di Reumatologia, Azienda Ospedaliera di Padova, Padova, Italy, ⁶Service de Rhumatologie, Hôpital Henri-Mondor, Creteil, France, ⁷NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom
Background/Purpose: In the SEKOIA study, strontium ranelate 2g/day has been demonstrated to reduce total WOMAC score, pain subscore and global knee pain assessed using a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].